Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Levens Website

David L. Levens, M.D., Ph.D.

Selected Publications

1)  Baranello L, Kouzine F, Levens D.
CTCF and cohesin cooperate to organize the 3D structure of the mammalian genome.
Proc. Natl. Acad. Sci. U.S.A. 111: 889-90, 2014.
[Journal]
2)  Kouzine F, Levens D, Baranello L.
DNA topology and transcription.
Nucleus. 5: [Epub ahead of print], 2014.
[Journal]
3)  Levens D, Corces V.
Editorial overview: Genome architecture and expression: The nucleus, top and bottom.
Curr. Opin. Genet. Dev. 25: v-vii, 2014.
[Journal]
4)  Luchenko VL, Litman T, Chakraborty AR, Heffner A, Devor C, Wilkerson J, Stein W, Robey RW, Bangiolo L, Levens D, Bates SE.
Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.
Mol Oncol. [Epub ahead of print], 2014.
[Journal]
5)  Levens D.
Cellular MYCro economics: Balancing MYC function with MYC expression.
Cold Spring Harb Perspect Med. 3, 2013.
[Journal]
6)  Baranello L, Kouzine F, Levens D.
DNA Topoisomerases: Beyond the standard role.
Transcription. 4, 2013.
[Journal]
7)  Kouzine F, Wojtowicz D, Yamane A, Resch W, Kieffer-Kwon KR, Bandle R, Nelson S, Nakahashi H, Awasthi P, Feigenbaum L, Menoni H, Hoeijmakers J, Vermeulen W, Ge H, Przytycka TM, Levens D, Casellas R.
Global regulation of promoter melting in naive lymphocytes.
Cell. 153: 988-99, 2013.
[Journal]
8)  Hu G, Cui K, Northrup D, Liu C, Wang C, Tang Q, Ge K, Levens D, Crane-Robinson C, Zhao K.
H2A.Z facilitates access of active and repressive complexes to chromatin in embryonic stem cell self-renewal and differentiation.
Cell Stem Cell. 12: 180-92, 2013.
[Journal]
9)  Matsushita K, Tamura M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Levens D, He L, Liu J, Yoshida M, Nomura F.
Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
Mol. Cancer Res. 11: 689-98, 2013.
[Journal]
10)  Levens D, Aplan PD.
Notching up MYC gives a LIC.
Cell Stem Cell. 13: 8-9, 2013.
[Journal]
11)  Rosales T, Nie Z, Kapoor V, Casellas R, Knutson JR, Levens D.
Partition of Myc into immobile vs. mobile complexes within nuclei.
Sci Rep. 3: 1953, 2013.
[Journal]
12)  Du X, Wojtowicz D, Bowers AA, Levens D, Benham CJ, Przytycka TM.
The genome-wide distribution of non-B DNA motifs is shaped by operon structure and suggests the transcriptional importance of non-B DNA structures in Escherichia coli.
Nucleic Acids Res. 41: 5965-77, 2013.
[Journal]
13)  Lai JP, Liu YC, Alimchandani M, Liu Q, Aung PP, Matsuda K, Lee CC, Tsokos M, Hewitt S, Rushing EJ, Tamura D, Levens DL, Digiovanna JJ, Fine HA, Patronas N, Khan SG, Kleiner DE, Oberholtzer JC, Quezado MM, Kraemer KH.
The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D).
Acta Neuropathol Commun. 1: 4, 2013.
[Journal]
14)  Kaur S, Soto-Pantoja DR, Stein EV, Liu C, Elkahloun AG, Pendrak ML, Nicolae A, Singh SP, Nie Z, Levens D, Isenberg JS, Roberts DD.
Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors.
Sci Rep. 3: 1673, 2013.
[Journal]
15)  Kouzine F, Gupta A, Baranello L, Wojtowicz D, Ben-Aissa K, Liu J, Przytycka TM, Levens D.
Transcription-dependent dynamic supercoiling is a short-range genomic force.
Nat. Struct. Mol. Biol. 20: 396-403, 2013.
[Journal]
16)  Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D.
c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.
Cell. 151: 68-79, 2012.
[Journal]
17)  Grøntved L, Bandle R, John S, Baek S, Chung H, Liu Y, Aguilera G, Oberholtzer C, Hager GL, Levens D.
Rapid Genome-Scale Mapping of Chromatin Accessibility in Tissue.
Epigenetics Chromatin. 5: 10, 2012.
[Journal]
18)  Lovén J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens DL, Lee TI, Young RA.
Revisiting global gene expression analysis.
Cell. 151: 476-82, 2012.
[Journal]
19)  Matsushita K, Kajiwara T, Tamura M, Satoh M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Yoshimoto R, Ito A, Kubo S, Natsume T, Levens D, Yoshida M, Nomura F.
SAP155-Mediated Splicing of FUSE-Binding Protein-Interacting Repressor Serves as a Molecular Switch for c-myc Gene Expression.
Mol Cancer Res. 10: 787-99, 2012.
[Journal]
20)  Salari R, Wojtowicz D, Zheng J, Levens D, Pilpel Y, Przytycka TM.
Teasing apart translational and transcriptional components of stochastic variations in eukaryotic gene expression.
PLoS Comput. Biol. 8: e1002644, 2012.
[Journal]
21)  Baranello L, Levens D, Gupta A, Kouzine F.
The importance of being supercoiled: How DNA mechanics regulate dynamic processes.
Biochim. Biophys. Acta. 1819: 632-8, 2012.
[Journal]
22)  Levens D, Benham CJ.
DNA stress and strain, in silico, in vitro and in vivo.
Phys Biol. 8: 035011, 2011.
[Journal]
23)  Liu J, Chung HJ, Vogt M, Jin Y, Malide D, He L, Dundr M, Levens D.
JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress.
EMBO J. 30: 846-58, 2011.
[Journal]
24)  Gonzales DA, De Torre C, Wang H, Devor CB, Munson PJ, Ying SX, Kern SJ, Petraitiene R, Levens DL, Walsh TJ, Suffredini AF.
Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia.
Proteomics Clin Appl. 5: 460, 2011.
[Journal]
25)  Kitamura A, Matsushita K, Takiguchi Y, Shimada H, Tada Y, Yamanaka M, Hiroshima K, Tagawa M, Tomonaga T, Matsubara H, Inoue M, Hasegawa M, Sato Y, Levens D, Tatsumi K, Nomura F.
Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.
Cancer Sci. 102: 1366-73, 2011.
[Journal]
26)  Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, Levens DL, Kelleher NL, Licht JD.
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
Blood. 117: 211-20, 2011.
[Journal]
27)  Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Weisenburger DD, Chan WC, Gascoyne RD, Levens D, Staudt LM.
Cooperative epigenetic modulation by cancer amplicon genes.
Cancer Cell. 18: 590-605, 2010.
[Journal]
28)  Levens D, Gupta A.
Molecular biology. Reliable noise.
Science. 327: 1088-9, 2010.
[Journal]
29)  Gonzales DA, De Torre C, Wang H, Devor CB, Munson PJ, Ying SX, Kern SJ, Petraitiene R, Levens DL, Walsh TJ, Suffredini AF.
Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia.
Proteomics. 10: 4270-80, 2010.
[Journal]
30)  Levens D.
You Don't Muck with MYC.
Genes Cancer. 1: 547-554, 2010.
[Journal]
31)  Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu M, Joos S, Devens F, Lichter P, Rieker RJ, Trojan J, Chung H, Levens DL, Zornig M.
Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth.
Hepatology. 50: 1121-9, 2009.
[Journal]
32)  Crichlow GV, Zhou H, Hsiao HH, Frederick KB, Debrosse M, Yang Y, Folta-Stogniew EJ, Chung HJ, Fan C, De la Cruz EM, Levens D, Lolis E, Braddock D.
Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.
EMBO J. 27: 277-89, 2008.
[Journal]
33)  Benjamin LR, Chung HJ, Sanford S, Kouzine F, Liu J, Levens D.
Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein.
Proc. Natl. Acad. Sci. U.S.A. 105: 18296-301, 2008.
[Journal]
34)  Levens D.
How the c-myc Promoter Works and Why It Sometimes Does Not.
J. Natl. Cancer Inst. Monographs. 41-3, 2008.
[Journal]
35)  Kim K, Choi J, Heo K, Kim H, Levens D, Kohno K, Johnson EM, Brock HW, An W.
Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription.
J. Biol. Chem. 283: 9113-26, 2008.
[Journal]
36)  Kouzine F, Sanford S, Elisha-Feil Z, Levens D.
The functional response of upstream DNA to dynamic supercoiling in vivo.
Nat. Struct. Mol. Biol. 15: 146-54, 2008.
[Journal]
37)  Wan F, Anderson DE, Barnitz RA, Snow A, Bidere N, Zheng L, Hegde V, Lam LT, Staudt LM, Levens D, Deutsch WA, Lenardo MJ.
Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation.
Cell. 131: 927-39, 2007.
[Journal]
38)  Kouzine F, Levens D.
Supercoil-driven DNA structures regulate genetic transactions.
Front. Biosci. 12: 4409-23, 2007.
[Journal]
39)  Matsushita K, Tomonaga T, Shimada H, Shioya A, Higashi M, Matsubara H, Harigaya K, Nomura F, Libutti D, Levens D, Ochiai T.
An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis.
Cancer Res. 66: 1409-17, 2006.
[Journal]
40)  Chung HJ, Liu J, Dundr M, Nie Z, Sanford S, Levens D.
FBPs are calibrated molecular tools to adjust gene expression.
Mol. Cell. Biol. 26: 6584-97, 2006.
[Journal]
41)  Liu J, Levens D.
Making myc.
Curr. Top. Microbiol. Immunol. 302: 1-32, 2006.
[Journal]
42)  Weber A, Gutierrez MI, Levens D.
The CT-element of the c-myc gene does not predispose to chromosomal breakpoints in Burkitt's lymphoma.
Cell. Oncol. 28: 31-5, 2006.
[Journal]
43)  Liu J, Kouzine F, Nie Z, Chung HJ, Elisha-Feil Z, Weber A, Zhao K, Levens D.
The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.
EMBO J. 25: 2119-30, 2006.
[Journal]
44)  Chung HJ, Levens D.
c-myc expression: keep the noise down!.
Mol. Cells. 20: 157-66, 2005.
[Journal]
45)  Weber A, Liu J, Collins I, Levens D.
TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression.
Mol Cell Biol. 25: 147-61, 2005.
[Journal]
46)  Huth JR, Yu L, Collins I, Mack J, Mendoza R, Isaac B, Braddock DT, Muchmore SW, Comess KM, Fesik SW, Clore GM, Levens D, Hajduk PJ.
NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter.
J Med Chem. 47: 4851-4857, 2004.
[Journal]
47)  Kouzine F, Liu J, Sanford S, Chung H, Levens D.
The dynamic response of upstream DNA to transcription generated torsional stress.
Nat Struct Mol Biol. 11: 1092-100, 2004.
[Journal]
48)  Levens DL.
Reconstructing MYC.
Genes Dev. 17: 1071-7, 2003.
[Journal]
49)  Levens D.
Disentangling the MYC web.
Proc Natl Acad Sci U S A. 99: 5757-9, 2002.
[Journal]
50)  Braddock DT, Baber JL, Levens D, Clore GM.
Molecular basis of sequence-specific single-stranded DNA recognition by KH domains: solution structure of a complex between hnRNP K KH3 and single-stranded DNA.
EMBO J. 21: 3476-85, 2002.
[Journal]
51)  Braddock DT, Louis JM, Baber JL, Levens D, Clore GM.
Structure and dynamics of KH domains from FBP bound to single-stranded DNA.
Nature. 415: 1051-6, 2002.
[Journal]
52)  Liu J, Akoulitchev S, Weber A, Ge H, Chuikov S, Libutti D, Wang XW, Conaway JW, Harris CC, Conaway RC, Reinberg D, Levens D.
Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum.
Cell. 104: 353-63, 2001.
[Journal]
53)  Collins I, Weber A, Levens D.
Transcriptional consequences of topoisomerase inhibition.
Mol Cell Biol. 21: 8437-51, 2001.
[Journal]
54)  Baber JL, Levens D, Libutti D, Tjandra N.
Chemical shift mapped DNA-binding sites and 15N relaxation analysis of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K.
Biochemistry. 39: 6022-32, 2000.
[Journal]
55)  He L, Liu J, Collins I, Sanford S, O'Connell B, Benham CJ, Levens D.
Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression.
EMBO J. 19: 1034-44, 2000.
[Journal]
56)  He L, Weber A, Levens D.
Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor.
Nucleic Acids Res. 28: 4558-65, 2000.
[Journal]
57)  Liu J, He L, Collins I, Ge H, Libutti D, Li J, Egly JM, Levens D.
The FBP interacting repressor targets TFIIH to inhibit activated transcription.
Mol Cell. 5: 331-41, 2000.
[Journal]
58)  Baber JL, Libutti D, Levens D, Tjandra N.
High precision solution structure of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K, a c-myc transcription factor.
J. Mol. Biol. 289: 949-62, 1999.
[Journal]
59)  Tomonaga T, Michelotti GA, Libutti D, Uy A, Sauer B, Levens D.
Unrestraining genetic processes with a protein-DNA hinge.
Mol. Cell. 1: 759-64, 1998.
[Journal]
60)  Levens D, Duncan RC, Tomonaga T, Michelotti GA, Collins I, Davis-Smyth T, Zheng T, Michelotti EF.
DNA conformation, topology, and the regulation of c-myc expression.
Curr. Top. Microbiol. Immunol. 224: 33-46, 1997.
[Journal]
61)  Michelotti EF, Sanford S, Levens D.
Marking of active genes on mitotic chromosomes.
Nature. 388: 895-9, 1997.
[Journal]
62)  Michelotti EF, Sanford S, Freije JM, MacDonald NJ, Steeg PS, Levens D.
Nm23/PuF does not directly stimulate transcription through the CT element in vivo.
J. Biol. Chem. 272: 22526-30, 1997.
[Journal]
63)  Duncan R, Collins I, Tomonaga T, Zhang T, Levens D.
A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strand-binding protein FBP.
Mol. Cell. Biol. 16: 2274-82, 1996.
[Journal]
64)  Tomonaga T, Levens D.
Activating transcription from single stranded DNA.
Proc. Natl. Acad. Sci. U.S.A. 93: 5830-5, 1996.
[Journal]
65)  Michelotti EF, Michelotti GA, Aronsohn AI, Levens D.
Heterogeneous nuclear ribonucleoprotein K is a transcription factor.
Mol. Cell. Biol. 16: 2350-60, 1996.
[Journal]
66)  Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D, Levens D.
Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo.
Mol. Cell. Biol. 16: 2656-69, 1996.
[Journal]
67)  Davis-Smyth T, Duncan RC, Zheng T, Michelotti G, Levens D.
The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators.
J. Biol. Chem. 271: 31679-87, 1996.
[Journal]
68)  Michelotti EF, Tomonaga T, Krutzsch H, Levens D.
Cellular nucleic acid binding protein regulates the CT element of the human c-myc protooncogene.
J. Biol. Chem. 270: 9494-9, 1995.
[Journal]
69)  Tomonaga T, Levens D.
Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator.
J. Biol. Chem. 270: 4875-81, 1995.
[Journal]
70)  Bazar L, Meighen D, Harris V, Duncan R, Levens D, Avigan M.
Targeted melting and binding of a DNA regulatory element by a transactivator of c-myc.
J. Biol. Chem. 270: 8241-8, 1995.
[Journal]
71)  Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M, Levens D.
A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.
Genes Dev. 8: 465-80, 1994.
[Journal]
72)  Gardner K, Moore TC, Davis-Smyth T, Krutzsch H, Levens D.
Purification and characterization of a multicomponent AP-1.junD complex from T cells. Dependence on a separate cellular factor for enhanced DNA binding activity.
J. Biol. Chem. 269: 32963-71, 1994.
[Journal]
73)  Farina AR, Davis-Smyth T, Gardner K, Levens D.
An early response of an AP1-junD complex during T-cell activation.
J. Biol. Chem. 268: 26466-75, 1993.
[Journal]
74)  Borden EC, Lotan R, Levens D, Young CW, Waxman S.
Differentiation therapy of cancer: laboratory and clinical investigations.
Cancer Res. 53: 4109-15, 1993.
[Journal]
75)  Takimoto M, Tomonaga T, Matunis M, Avigan M, Krutzsch H, Dreyfuss G, Levens D.
Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro.
J. Biol. Chem. 268: 18249-58, 1993.
[Journal]
76)  Avigan MI, Strober B, Levens D.
A far upstream element stimulates c-myc expression in undifferentiated leukemia cells.
J. Biol. Chem. 265: 18538-45, 1990.
[Journal]
77)  Levens D.
Development and cancer: common themes?.
Lab. Invest. 63: 429-31, 1990.
[Journal]
78)  Zajac-Kaye M, Levens D.
Phosphorylation-dependent binding of a 138-kDa myc intron factor to a regulatory element in the first intron of the c-myc gene.
J. Biol. Chem. 265: 4547-51, 1990.
[Journal]
79)  Quinn JP, Takimoto M, Iadarola M, Holbrook N, Levens D.
Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers.
J. Virol. 63: 1737-42, 1989.
[Journal]
80)  Takimoto M, Quinn JP, Farina AR, Staudt LM, Levens D.
fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene.
J. Biol. Chem. 264: 8992-9, 1989.
[Journal]
81)  Quinn JP, Farina AR, Gardner K, Krutzsch H, Levens D.
Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer.
Mol. Cell. Biol. 9: 4713-21, 1989.
[Journal]
82)  Zajac-Kaye M, Gelmann EP, Levens D.
A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein.
Science. 240: 1776-80, 1988.
[Journal]
83)  Zajac-Kaye M, Avigan M, Takimoto M, Pittaluga S, Quinn J, Gelmann E, Levens D.
Multifactorial regulation of the human c-myc oncogene.
Curr. Top. Microbiol. Immunol. 141: 247-52, 1988.
[Journal]
84)  Gimble JM, Levens D, Max EE.
B-cell nuclear proteins binding in vitro to the human immunoglobulin kappa enhancer: localization by exonuclease protection.
Mol. Cell. Biol. 7: 1815-22, 1987.
[Journal]
85)  Quinn JP, Holbrook N, Levens D.
Binding of a cellular protein to the gibbon ape leukemia virus enhancer.
Mol. Cell. Biol. 7: 2735-44, 1987.
[Journal]
86)  Hay N, Bishop JM, Levens D.
Regulatory elements that modulate expression of human c-myc.
Genes Dev. 1: 659-71, 1987.
[Journal]
87)  Bates S, McKeever P, Masur H, Levens D, Macher A, Armstrong G, Magrath IT.
Myelopathy following intrathecal chemotherapy in a patient with extensive Burkitt"s lymphoma and altered immune status.
Am. J. Med. 78: 697-702, 1985.
[Journal]
88)  Levens D, Howley PM.
Novel method for identifying sequence-specific DNA-binding proteins.
Mol. Cell. Biol. 5: 2307-15, 1985.
[Journal]
89)  Silver MA, Macher AM, Reichert CM, Levens DL, Parrillo JE, Longo DL, Roberts WC.
Cardiac involvement by Kaposi"s sarcoma in acquired immune deficiency syndrome (AIDS).
Am. J. Cardiol. 53: 983-5, 1984.
[Journal]
90)  Reichert CM, O'Leary TJ, Levens DL, Simrell CR, Macher AM.
Autopsy pathology in the acquired immune deficiency syndrome.
Am. J. Pathol. 112: 357-82, 1983.
[Journal]
91)  Edwards JC, Levens D, Rabinowitz M.
Analysis of transcriptional initiation of yeast mitochondrial DNA in a homologous in vitro transcription system.
Cell. 31: 337-46, 1982.
[Journal]
92)  Montoya J, Christianson T, Levens D, Rabinowitz M, Attardi G.
Identification of initiation sites for heavy-strand and light-strand transcription in human mitochondrial DNA.
Proc. Natl. Acad. Sci. U.S.A. 79: 7195-9, 1982.
[Journal]
93)  Lustig A, Levens D, Rabinowitz M.
The biogenesis and regulation of yeast mitochondria RNA polymerase.
J. Biol. Chem. 257: 5800-8, 1982.
[Journal]
94)  Christianson T, Edwards J, Levens D, Locker J, Rabinowitz M.
Transcriptional initiation and processing of the small ribosomal RNA of yeast mitochondria.
J. Biol. Chem. 257: 6494-500, 1982.
[Journal]
95)  Levens D, Morimoto R, Rabinowitz M.
Mitochondrial transcription complex from Saccharomyces cerevisiae.
J. Biol. Chem. 256: 1466-72, 1981.
[Journal]
96)  Levens D, Lustig A, Rabinowitz M.
Purification of mitochondrial RNA polymerase from Saccharomyces cerevisiae.
J. Biol. Chem. 256: 1474-81, 1981.
[Journal]
97)  Levens D, Ticho B, Ackerman E, Rabinowitz M.
Transcriptional initiation and 5" termini of yeast mitochondrial RNA.
J. Biol. Chem. 256: 5226-32, 1981.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 6/30/2014.